This study aims to describe and characterize incident HR-HPV infections and associated diseases in HIV-infected women. 805 HIV-infected women enrolled in the VALHIDATE Study were screened and followed-up for HPV by co-testing. Social, behavioral and health data were collected. HPV-DNA positive samples were typed using a commercial kit or RFLP analysis. Conventional Pap-smears were evaluated using the 2001 Bethesda System. The participants with abnormal cytological results were referred for colposcopy. 565 HIV-infected women (median age: 43 years) were analysed, 40.9% had >5 lifetime sexual partners, 77.2% contracted HIV through sexual intercourse, 93% were receiving antiretroviral treatment and 77.3% had undetectable HIV-RNA. The women underwent 1254 follow-ups (median follow-up: 33 months) for 1430.6 PersonYear-Follow-Up. 37.4% of baseline HPV-negative women acquired incident HPV-infections, 69.6% of which were HR-HPVs. HPV-53 was the most common HPV type detected (9.3%). 18.2% of women showed incident or progressive cytological abnormalities (7.8% ASC-US, 9.7% LSIL and 0.6% HSIL) and colposcopy revealed CIN2 (N = 2), CIN1 (N = 2) and VIN3 (N = 1). The preventable fraction of incident infections was 11.3%, 16.7%, and 35.2% for the 2v-4v-9v-HPV vaccines respectively (χ2 p < 0.0001). The overall burden of incident lesions attributable to the vaccine types were 9.1% for 2v-, 14.5% for 4v- and 30.9% for 9v-vaccine. High HPV incidence rates and high percentages of multiple HR-HPV infections were observed in a cohort of HIV-infected women receiving effective antiretroviral treatment. Primary prevention strategies based on the new 9v-HPV vaccine may help to prevent incident infections and disease progression in this cohort of women.
Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV/AIDS / G. Orlando, E.R. Frati, M.M. Fasolo, S. Bianchi, A. Matteelli, F. Mazza, G. Rizzardini, A. Amendola, E. Tanzi. - In: HUMAN VACCINES & IMMUNOTHERAPEUTICS. - ISSN 2164-5515. - 15:7-8(2019 Aug), pp. 1904-1910.
|Titolo:||Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV/AIDS|
FRATI, ELENA ROSANNA (Secondo)
AMENDOLA, ANTONELLA (Penultimo)
TANZI, ELISABETTA (Ultimo) (Corresponding)
|Parole Chiave:||HPV incident infections; HPV vaccines; HR-HPV; Women living with HIV/AIDS; cytology|
|Settore Scientifico Disciplinare:||Settore MED/42 - Igiene Generale e Applicata|
Settore MED/07 - Microbiologia e Microbiologia Clinica
|Data di pubblicazione:||ago-2019|
|Data ahead of print / Data di stampa:||12-ott-2018|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1080/21645515.2018.1528834|
|Appare nelle tipologie:||01 - Articolo su periodico|
File in questo prodotto:
|Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV AIDS.pdf||Publisher's version/PDF||Open Access Visualizza/Apri|
|21645515.2018.pdf||Publisher's version/PDF||Open Access Visualizza/Apri|